Achillion collapses after Friday's AH rout

Needless to say, Achillion Pharmaceuticals (ACHN -55%) is having a rough day.

The stock has lost over half its market value after Friday's pipeline "update."

Downgrades are out from Piper, William Blair, JMP, and BofA.

SA contributor Stephen Simpson calls the stock "burnt toast."

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs